A Phase 1 Trial of GEN1119 in Participants With Solid Tumors
NCT07695831
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
112
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumours
Interventions
DRUG:
GEN1119
Sponsor
Genmab